Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Cough Capture as a Portal Into the Lung
The update announces ongoing recruitment for a clinical trial exploring cough capture as a portal into the lung to study lung diseases, incl…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) [Phase 3]
Phase 3 trial evaluating BI 1015550 for progressive fibrosing interstitial lung diseases has completed and posted results.
-
EMA approval · 2026-01-06EMA Authorised: Ofev (nintedanib) — Boehringer Ingelheim International GmbH
The European Medicines Agency authorised a label expansion for Ofev (nintedanib) to cover additional interstitial lung diseases, including s…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency [Phase 2]
Phase 2 clinical trial investigating senolytic therapy for interstitial lung disease in people with common variable immunodeficiency; the st…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease [Phase 4]
A Phase 4 clinical trial is recruiting to test tetrandrine tablets for connective tissue disease–related interstitial lung disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Evaluation of the Reproducibility of the Automated Measurement of the Extent of ILD on Chest CT [NA]
This clinical trial update describes a study evaluating the reproducibility of an automated measurement of the extent of interstitial lung d…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases [Phase 3]
ClinicalTrials.gov update on a Phase 3 study evaluating rituximab in combination with mycophenolate mofetil for interstitial lung diseases. …
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Safety Profile of Ultrasound-guided Transparietal Lung Biopsy in Patients With Diffuse Interstitial Lung Disease [NA]
An update on a trial assessing the safety of ultrasound-guided transparietal lung biopsy in patients with interstitial lung disease; the stu…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
A clinical trial in China is evaluating whether generative AI can improve the diagnosis of complications associated with rheumatoid arthriti…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Functional MRI for Monitoring Progression and Assessing Trends in ILD [NA]
A University Hospital Heidelberg trial uses functional MRI to monitor progression and assess trends in interstitial lung diseases.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Routine vs On-demand ECMO for Lung Transplantation [NA]
A clinical trial update indicates a study comparing routine versus on-demand ECMO support for lung transplantation is currently recruiting a…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Clinical Relevance of Thoracic Echography for the Early Diagnosis of Interstitial Lung Disease in Systemic Scleroderma - Pilot Study [NA]
A completed pilot study evaluating whether thoracic echography can aid early diagnosis of interstitial lung disease in systemic sclerosis. T…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Implementation of Home Monitoring in Patients With Pulmonary Fibrosis [NA]
Recruitment is ongoing for a clinical study evaluating home monitoring in patients with pulmonary fibrosis and interstitial lung disease.
-
EMA approval · 2025-12-19EMA Authorised: Pirfenidone Viatris (Pirfenidone) — Viatris Limited
EMA authorised Pirfenidone Viatris as a generic version of pirfenidone for idiopathic pulmonary fibrosis in the European Union, expanding ac…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: The Effect of Video Game-Based Exercise Training in Patients With Interstitial Lung Disease [NA]
This clinical trial update describes a study evaluating video game-based exercise training in patients with interstitial lung disease. The t…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung Diseases [NA]
A clinical trial comparing exercise performance on ambient air versus low-flow oxygen therapy in people with chronic lung diseases has compl…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE) [Phase 3]
This update outlines a Phase 3 clinical trial evaluating the long-term safety and efficacy of belimumab in adults with interstitial lung dis…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis
A long-term observational registry is underway to observe the effects of nintedanib in people with scleroderma-related interstitial lung dis…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Hydroxychloroquine (HCQ) in Pediatric Interstitial Lung Disease (ILD) [Phase 2]
A Phase 2 study of hydroxychloroquine in children with interstitial lung disease was terminated, and the results have been posted (as of 202…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension [Phase 2]
A Phase 2 trial evaluating treprostinil for interstitial lung disease-associated pulmonary hypertension has completed and posted results.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
Clinical trial conducted by Medical University Innsbruck aims to detect pleuropulmonary manifestations in patients with rheumatoid arthritis…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) [Phase 3]
This is an open-label extension study for Treprostinil Palmitil Inhalation Powder (TPIP) in participants with pulmonary hypertension associa…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors
Boehringer Ingelheim completed a study to develop a screening tool for detecting interstitial lung disease in people with rheumatoid arthrit…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Genentech Validation Tool for Pulmonary Fibrosis
A clinical trial update indicates a Genentech validation tool for pulmonary fibrosis is being evaluated for interstitial lung disease, with …
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease [Phase 2]
A Phase 2 clinical trial evaluating abatacept for common variable immunodeficiency with interstitial lung disease is currently recruiting.